IP Library Granted Patent US 6,965,023
Granted Patent B2
US 6,965,023 · App. 10/001,254 · Granted Nov 15, 2005

Death domain proteins

Assignee: The Burnham Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,965,023
App. No.
10/001,254
Granted
Nov 15, 2005
Kind
B2
Abstract

In accordance with the present invention, there are provided novel Death Domain (DD), Death Effector Domain (DED) and NB-ARC domain proteins. The invention also provides nucleic acid molecules encoding DD, DED and NB-ARC domain proteins, vectors containing these nucleic acid molecules and host cells containing the vectors. The invention also provides antibodies that can specifically bind to invention DDs, DEDs or NB-ARC domains. Such DDs, DEDs and NB-ARC domains and/or anti-DD, anti-DED or anti-NB-ARC domain antibodies are useful for discovery of drugs that suppress infection, autoimmunity, inflammation, allergy, allograft rejection, sepsis, and other diseases.

Claims (13)

1. An isolated nucleic acid molecule consisting of

DNA encoding a polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:6.

2. A vector that expresses the nucleic acid molecule of claim 1 .

3. Recombinant cells that express the nucleic acid molecule of claim 1 .

4. The isolated nucleic acid molecule of claim 1 , said nucleic acid consisting of the sequence of SEQ ID NO:5.

5. A method for expression of a polypeptide consisting of an amino acid of SEQ ID NO:6, said method comprising culturing cells of claim 3 under conditions suitable for expression of the polypeptide consisting of said amino acid of SEQ ID NO:6.

6. An isolated nucleic acid molecule consisting of a label linked to DNA consisting of

DNA encoding a polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:6.

7. The isolated nucleic acid of claim 6 , said DNA consisting of a sequence set forth in SEQ ID NO:5.

8. The isolated nucleic acid of claim 6 , said label being a fluorescent labeling agent.

9. The isolated nucleic acid of claim 6 , wherein said label is a radioactive element.

10. The isolated nucleic acid of claim 6 , wherein said label is an enzyme.

11. The isolated nucleic acid of claim 10 , wherein said label is selected from the group consisting of horseradish peroxidase and glucose oxidase.

Assignments (3)
CONFIRMATORY LICENSE Recorded Feb 25, 2022
From: SANFORD BURNHAM PREBS MED DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 059250/0438 →
CONFIRMATORY LICENSE Recorded Aug 27, 2019
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 050179/0798 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2002
From: REED, JOHN C.; GODZIK, ADAM; PAWLOWSKI, KRZYSZTOF; FIORENTINO, LOREDANA; LEE, SUG HYUNG; ROTH, WILFRIED; STENNER-LIEWEN, FRANK
To: BURNHAM INSTITUTE, THE
Reel/Frame 012994/0697 →
Continuity (3)
Provisional Application 6030188900 · Jun 29, 2001
Provisional Application 6036736000 · Nov 17, 2000
Related Publication 20030049702A1 · Mar 13, 2003